Global Drug Facility as main platform for TB medicinesGDF slashed the price of cycloserine by 55% earlier this year
Race to Reach the SDG Finish LineVideo statement from Dr Lucica Ditiu
Technical Cooperation Agreement with the Global FundPartnership reinforces commitment for engagement of communities
Global Plan for TB 2016-2020 final regional consultationGreat momentum towards a final draft
Challenge Facility for Civil Society Launches Round 7Call for applications for Round 7 of CFCS
08 October - RNTCP National Review MeetingRNTCP National Review Meeting
08 October 2015 - The latest review meeting was held in Nagpur, Maharashtra from 14 to 16 September 2015. The National Review Meeting of India’s Revised National TB Control Programme (RNTCP) is a biannual feature, where State Programme Officers from States and Union Territories participate to review and discuss progress towards TB care and control targets in their respective regions.
05 October - USAID Supports Cross Border TB Prevention and Control Among...USAID Supports Cross Border TB Prevention and Control Among Migrants in Central Asia
05 October 2015 - On September 29 and 30, the Tajik Ministry of Health and Social Protection convened a regional workshop on strengthening cross-border tuberculosis (TB) control, prevention and care among migrant workers from Central Asia and their families. The workshop funded by the USAID TB Control Program, gathered representatives from health and migration departments of Kazakhstan, Tajikistan, Turkmenistan, the Kyrgyz Republic and the Russian Federation to discuss improving access to TB care for migrants in the region.
28 September - Answer to costly pills: Stop TB Partnership's Global Drug Facility...Answer to costly pills: Stop TB Partnership's Global Drug Facility -- the platform for TB medicines amidst recent US drug storm
28 September 2015 - Geneva, Switzerland - The US market for cycloserine - a drug used to treat multi-drug resistant tuberculosis (MDR-TB) - had a 2,000 percent price increase when it was recently sold to Rodelis Therapeutics. Due to public outcry, the massive overnight price increase for this specialized tuberculosis drug was rescinded on Monday after the company that acquired the drug’s rights returned it to its previous owner.
27 September - The Race to Reach the SDG Finish Line - Leave No One BehindThe Race to Reach the SDG Finish Line - Leave No One Behind
27th September 2015, New York, United States - Among the long motorcades accompanying Heads of State and the many high-level events here at the UN Sustainable Development Goals (SDG) Summit in New York, it’s easy to forget that the key theme of the Summit is ‘Leave No One Behind’.
24 September - Another step forward in awareness and eradication of TB in Karachi...Another step forward in awareness and eradication of TB in Karachi, Pakistan
24 September 2015 - Taj Clinics and Diagnostics and Tabeer (NGO), a partner of the Stop TB Partnership, held a free TB diagnosis and management camp at Rajput Colony, Gulshan-e-Iqbal, Karachi. The Rajput Colony is a slum dwelling with a high prevalence of tuberculosis due to poor hygiene and improper ventilation.
24 September - Nigeria Stop TB Partnership website launchedNigeria Stop TB Partnership website launched
24 September 2015 - The Nigeria Stop TB Partnership (NSTBP) has officially launched their website, http://stoptbng.org, at a board meeting held at the KNCV Head office in Abuja.
24 September - The Global Fund Advocates Network Launches its Speakers BureauThe Global Fund Advocates Network Launches its Speakers Bureau
24th September 2015 - The Global Fund Advocated Network (GFAN) has recruited a group of eight impressive speakers from around the world who have been affected by HIV, TB and/or malaria and can speak on a variety of issues related to these epidemics. They are available now for Global Fund resource mobilization advocacy.
23 September - Webinar outlines up-to-date information on the use of bedaquilineWebinar outlines up-to-date information on the use of bedaquiline
23 September 2015 - On September 10, Dr.Jennifer Furin, in collaboration with the TB team at USAID and SIAPS, presented up-to-date information on the use of bedaquiline for treatment of TB patients under the USAID-Janssen bedaquiline donation program. This webinar is particularly useful for consultants, program managers, and clinicians working in the field of drug-resistant TB.
23 September - Experience sharing workshop on the introduction of new drugs...Experience sharing workshop on the introduction of new drugs for drug-resistant TB in the WHO European Region
23 September 2015 - Copenhagen, Denmark -- Today marked the end of a two-day joint WHO EURO-HQ meeting that focussed on sharing experiences on the introduction of new drugs for drug-resistant TB treatment in the WHO European Region in Copenhagen, Denmark.
November 16 2015
November 17 2015
November 29 2015
We set goals to fight TB globally. We grant funds to reach and treat people living with TB. We strive to raise the profile and understanding of TB. We bring the voice of TB communities to the fore. We procure drugs and diagnostics.
We work together with our partners to create a world without TB.
We are the Stop TB Partnership.